180 related articles for article (PubMed ID: 33973404)
1. Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5,900 Patients From Israel.
Ben-Shabat N; Shabat A; Watad A; Kridin K; Bragazzi NL; McGonagle D; Comaneshter D; Cohen AD; Amital H
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1614-1622. PubMed ID: 33973404
[TBL] [Abstract][Full Text] [Related]
2. The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort.
Liew JW; Jafarzadeh SR; Dubreuil M; Heckbert SR; Mooney SJ; Brown MA; Ishimori ML; Reveille JD; Ward MM; Weisman MH; Gensler LS
J Rheumatol; 2022 Mar; 49(3):274-280. PubMed ID: 34853088
[TBL] [Abstract][Full Text] [Related]
3. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
4. Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study.
Choi SJ; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
Korean J Intern Med; 2020 May; 35(3):723-731. PubMed ID: 31870134
[TBL] [Abstract][Full Text] [Related]
5. Low Vitamin D Levels Predict Mortality in Ankylosing Spondylitis Patients: A Nationwide Population-Based Cohort Study.
Ben-Shabat N; Watad A; Shabat A; Bragazzi NL; Comaneshter D; Cohen AD; Amital H
Nutrients; 2020 May; 12(5):. PubMed ID: 32414130
[TBL] [Abstract][Full Text] [Related]
6. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.
Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Arthritis Rheumatol; 2014 May; 66(5):1282-90. PubMed ID: 24782185
[TBL] [Abstract][Full Text] [Related]
7. The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
Kim Y; Park S; Kim HS
Clin Rheumatol; 2018 Dec; 37(12):3275-3284. PubMed ID: 30251059
[TBL] [Abstract][Full Text] [Related]
8. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
9. Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.
Hebeisen M; Neuenschwander R; Scherer A; Exer P; Weber U; Tamborrini G; Micheroli R; Wildi LM; Zufferey P; Nissen MJ; Villiger PM; Bernhard J; Finckh A; van der Horst-Bruinsma IE; Sieper J; Landewé R; van der Heijde D; Ciurea A;
J Rheumatol; 2018 Apr; 45(4):506-512. PubMed ID: 29449504
[TBL] [Abstract][Full Text] [Related]
10. Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register.
Kristensen LE; Karlsson JA; Englund M; Petersson IF; Saxne T; Geborek P
Arthritis Care Res (Hoboken); 2010 Oct; 62(10):1362-9. PubMed ID: 20506310
[TBL] [Abstract][Full Text] [Related]
11. [Relapse of ankylosing spondylitis and its predictors after withdrawal of tumor necrosis factor-α inhibitors: a 52-week follow-up study].
Tang C; Chen F; Zheng S; Wu L; Chen S; Zhu J; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 May; 41(5):633-639. PubMed ID: 34134948
[TBL] [Abstract][Full Text] [Related]
12. Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea.
Jeong H; Eun YH; Kim IY; Kim H; Ahn JK; Lee J; Koh EM; Cha HS
Korean J Intern Med; 2018 Mar; 33(2):407-416. PubMed ID: 27729625
[TBL] [Abstract][Full Text] [Related]
13. Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study.
Park JW; Kim HA; Shin K; Park YB; Kim TH; Song YW; Lee EY
Arthritis Res Ther; 2019 Jul; 21(1):163. PubMed ID: 31272498
[TBL] [Abstract][Full Text] [Related]
14. The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors.
Koo BS; Lim YC; Lee MY; Jeon JY; Yoo HJ; Oh IS; Shin JY; Kim TH
Mod Rheumatol; 2021 Nov; 31(6):1192-1201. PubMed ID: 33494621
[TBL] [Abstract][Full Text] [Related]
15. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
16. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
17. Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing Spondylitis.
Merjanah S; Liew JW; Bihn J; Fillmore NR; Brophy MT; Do NV; Dubreuil M
Arthritis Care Res (Hoboken); 2023 Dec; 75(12):2481-2488. PubMed ID: 37308459
[TBL] [Abstract][Full Text] [Related]
18. TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: Results from a nationwide study.
Watad A; McGonagle D; Anis S; Carmeli R; Cohen AD; Tsur AM; Ben-Shabat N; Luigi Bragazzi N; Lidar M; Amital H
Pharmacol Res; 2022 Aug; 182():106325. PubMed ID: 35752359
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs in patients with stable ankylosing spondylitis receiving tumor necrosis factor inhibitor: continued vs withdrawn.
Park JH; Kwon OC; Park MC
Clin Rheumatol; 2020 Dec; 39(12):3669-3675. PubMed ID: 32447601
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study.
Capkin E; Karkucak M; Cosar AM; Ak E; Karaca A; Gokmen F; Budak BS; Tosun M
Int J Rheum Dis; 2015 Jun; 18(5):548-52. PubMed ID: 24612551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
